vs

Side-by-side financial comparison of FGI Industries Ltd. (FGI) and SCYNEXIS INC (SCYX). Click either name above to swap in a different company.

FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $18.6M, roughly 1.6× SCYNEXIS INC). SCYNEXIS INC runs the higher net margin — 65.7% vs -8.6%, a 74.4% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs -14.4%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs -0.5%).

FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.

SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.

FGI vs SCYX — Head-to-Head

Bigger by revenue
FGI
FGI
1.6× larger
FGI
$30.5M
$18.6M
SCYX
Growing faster (revenue YoY)
SCYX
SCYX
+1822.9% gap
SCYX
1808.5%
-14.4%
FGI
Higher net margin
SCYX
SCYX
74.4% more per $
SCYX
65.7%
-8.6%
FGI
Faster 2-yr revenue CAGR
SCYX
SCYX
Annualised
SCYX
268.5%
-0.5%
FGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FGI
FGI
SCYX
SCYX
Revenue
$30.5M
$18.6M
Net Profit
$-2.6M
$12.3M
Gross Margin
26.7%
Operating Margin
-2.2%
56.3%
Net Margin
-8.6%
65.7%
Revenue YoY
-14.4%
1808.5%
Net Profit YoY
-553.1%
376.5%
EPS (diluted)
$-1.63
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FGI
FGI
SCYX
SCYX
Q4 25
$30.5M
$18.6M
Q3 25
$35.8M
$334.0K
Q2 25
$31.0M
$1.4M
Q1 25
$33.2M
$257.0K
Q4 24
$35.6M
$977.0K
Q3 24
$36.1M
$660.0K
Q2 24
$29.4M
$736.0K
Q1 24
$30.8M
$1.4M
Net Profit
FGI
FGI
SCYX
SCYX
Q4 25
$-2.6M
$12.3M
Q3 25
$-1.7M
$-8.6M
Q2 25
$-1.2M
$-6.9M
Q1 25
$-629.1K
$-5.4M
Q4 24
$-402.3K
Q3 24
$-550.1K
$-2.8M
Q2 24
$163.6K
$-14.5M
Q1 24
$-412.2K
$411.0K
Gross Margin
FGI
FGI
SCYX
SCYX
Q4 25
26.7%
Q3 25
26.5%
Q2 25
28.1%
Q1 25
26.8%
Q4 24
24.6%
Q3 24
25.8%
Q2 24
30.5%
Q1 24
27.4%
Operating Margin
FGI
FGI
SCYX
SCYX
Q4 25
-2.2%
56.3%
Q3 25
1.0%
-2516.5%
Q2 25
-2.7%
-701.0%
Q1 25
-3.9%
-3350.2%
Q4 24
-3.5%
Q3 24
-0.2%
-1563.6%
Q2 24
-1.5%
-1255.0%
Q1 24
-1.0%
-692.5%
Net Margin
FGI
FGI
SCYX
SCYX
Q4 25
-8.6%
65.7%
Q3 25
-4.6%
-2572.2%
Q2 25
-4.0%
-504.8%
Q1 25
-1.9%
-2097.7%
Q4 24
-1.1%
Q3 24
-1.5%
-425.5%
Q2 24
0.6%
-1964.4%
Q1 24
-1.3%
29.9%
EPS (diluted)
FGI
FGI
SCYX
SCYX
Q4 25
$-1.63
$0.25
Q3 25
$-0.86
$-0.17
Q2 25
$-0.64
$-0.14
Q1 25
$-0.07
$-0.11
Q4 24
$-0.38
Q3 24
$-0.29
$-0.06
Q2 24
$0.08
$-0.30
Q1 24
$-0.04
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FGI
FGI
SCYX
SCYX
Cash + ST InvestmentsLiquidity on hand
$1.9M
$40.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$17.3M
$49.4M
Total Assets
$69.5M
$59.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FGI
FGI
SCYX
SCYX
Q4 25
$1.9M
$40.0M
Q3 25
$1.9M
$37.9M
Q2 25
$2.5M
$44.8M
Q1 25
$1.2M
$40.6M
Q4 24
$4.6M
$59.3M
Q3 24
$3.0M
$68.8M
Q2 24
$1.3M
$73.0M
Q1 24
$3.3M
$80.2M
Stockholders' Equity
FGI
FGI
SCYX
SCYX
Q4 25
$17.3M
$49.4M
Q3 25
$19.7M
$36.4M
Q2 25
$21.3M
$44.5M
Q1 25
$21.8M
$50.5M
Q4 24
$22.3M
$55.1M
Q3 24
$23.5M
$58.5M
Q2 24
$23.8M
$60.4M
Q1 24
$23.9M
$74.1M
Total Assets
FGI
FGI
SCYX
SCYX
Q4 25
$69.5M
$59.0M
Q3 25
$73.0M
$51.1M
Q2 25
$71.7M
$60.7M
Q1 25
$68.5M
$67.9M
Q4 24
$75.5M
$90.6M
Q3 24
$74.7M
$99.0M
Q2 24
$69.9M
$107.8M
Q1 24
$68.6M
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FGI
FGI
SCYX
SCYX
Operating Cash FlowLast quarter
$2.3M
$18.4M
Free Cash FlowOCF − Capex
$2.3M
FCF MarginFCF / Revenue
7.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.50×
TTM Free Cash FlowTrailing 4 quarters
$-212.5K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FGI
FGI
SCYX
SCYX
Q4 25
$2.3M
$18.4M
Q3 25
$-1.9M
$-8.7M
Q2 25
$7.6M
$-7.5M
Q1 25
$-7.4M
$-7.5M
Q4 24
$617.4K
$-24.0M
Q3 24
$-915.0K
$765.0K
Q2 24
$862.1K
$-10.9M
Q1 24
$-8.0M
$-4.0M
Free Cash Flow
FGI
FGI
SCYX
SCYX
Q4 25
$2.3M
Q3 25
$-2.1M
Q2 25
$7.4M
Q1 25
$-7.7M
Q4 24
$-214.1K
Q3 24
$-1.1M
Q2 24
$281.5K
Q1 24
$-8.6M
FCF Margin
FGI
FGI
SCYX
SCYX
Q4 25
7.5%
Q3 25
-5.9%
Q2 25
23.8%
Q1 25
-23.3%
Q4 24
-0.6%
Q3 24
-3.0%
Q2 24
1.0%
Q1 24
-28.0%
Capex Intensity
FGI
FGI
SCYX
SCYX
Q4 25
0.2%
Q3 25
0.7%
Q2 25
0.7%
Q1 25
1.1%
Q4 24
2.3%
Q3 24
0.5%
Q2 24
2.0%
Q1 24
2.0%
Cash Conversion
FGI
FGI
SCYX
SCYX
Q4 25
1.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
5.27×
Q1 24
-9.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FGI
FGI

Sanitaryware$19.1M63%
Shower System$5.8M19%
Kitchen And Bath Other$3.3M11%
Bath Furniture Products$2.3M7%

SCYX
SCYX

Glaxosmithkline Intellectual Property$17.2M92%
Products$1.4M8%

Related Comparisons